The Blood Screening Market size is USD 3.7 Bn in 2026.
The Blood Screening Market is projected to grow at a CAGR of 9% by 2033.
The Blood Screening Market growth is driven by rising infectious disease prevalence, increasing blood transfusions and donations, mandatory screening regulations, and an expanding geriatric population.
North America is the dominating region for the Blood Screening Market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Danaher Corporation are some leading industry players in the Blood Screening Market.